{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T04:43:35Z","timestamp":1765082615528,"version":"3.46.0"},"reference-count":33,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,1,24]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Treatment of latent tuberculosis (TB) infection (LTBI) is an important component of the End-TB strategy. However, the number of individuals who successfully complete LTBI treatment remains low as there are losses at all steps in the LTBI \u2018cascade-of-care\u2019. The reasons for these losses are variable and highly dependent on the setting. We have planned a trial of a standardised public health approach to strengthen the management of household contacts (HHCs) of newly diagnosed patients with pulmonary TB. Assessing costs related to approach is a secondary objective of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A cluster randomised trial will be conducted in 24 randomisation units (health facilities or groups of health facilities) in five countries. In Phase 1, at intervention sites, we will conduct a standardised assessment of the current LTBI programme, with a focus on cascade-of-care endpoints. Standardised open-ended questionnaires on practices, knowledge, attitudes and beliefs regarding TB prevention are then administered to key patient groups and healthcare workers. At each site, local stake-holders will review study findings and select solutions based on their acceptability, cost and effectiveness. In Phase 2, intervention clinics will implement the selected solutions, along with contact measurement registries and regular in-service LTBI management training. Control sites will continue their usual LTBI care with no explicit evaluation, strengthening or training activities. The primary study outcome is the number of HHC initiating LTBI treatment per newly diagnosed active TB patient, within 3 months of diagnosis of the index patient. An intention-to-treat analysis will be performed, using a Poisson regression approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval from the MUHC ethical review board (ERB) was obtained in November 2015. During the study standardised tools will be developed and made publicly available. Key study findings and novel methodologic contributions will be detailed in publications and other dissemination activities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT02810678\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\">NCT02810678<\/jats:ext-link>\n                      ; Pre-Results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-025831","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T05:35:56Z","timestamp":1553146556000},"page":"e025831","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct02810678","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"given":"Olivia","family":"Oxlade","sequence":"first","affiliation":[{"name":"McGill International TB Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, McGill University, Montreal, Quebec, Canada"},{"name":"Internal Medicine Graduate Program, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Benedetti","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00eanonli","family":"Adjobimey","sequence":"additional","affiliation":[{"name":"Centre National Hospitalier, Universitaire de Pneumo-Pthisiologie de Cotonou, Cotonou, Benin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria J","family":"Cook","sequence":"additional","affiliation":[{"name":"BC Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Fisher","sequence":"additional","affiliation":[{"name":"University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory James","family":"Fox","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Fregonese","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panji","family":"Hadisoemarto","sequence":"additional","affiliation":[{"name":"Department of Public Health, Faculty of Medicine, TB-HIV Research Center, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip C","family":"Hill","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Centre for International Health, University of Otago, Otago, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Johnston","sequence":"additional","affiliation":[{"name":"BC Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Long","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Obeng","sequence":"additional","affiliation":[{"name":"Ministry of Health, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rovina","family":"Ruslami","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Medicine, TB-HIV Research Center, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Valiquette","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"2025120619244540000_9.3.e025831.1","unstructured":"Global Tuberculosis Report 2017. World Health Organization, 2017. http:\/\/www.who.int\/tb\/publications\/global_report\/gtbr2017_main_text.pdf?ua=1 (accessed 2 Aug 2018)."},{"key":"2025120619244540000_9.3.e025831.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"2025120619244540000_9.3.e025831.3","unstructured":"Sustainable Development Goals. United Nations of Sustainable Development. United Nations, 2018. http:\/\/www.un.org\/sustainabledevelopment\/sustainable-development-goals\/ (accessed 2 Aug 2018)."},{"key":"2025120619244540000_9.3.e025831.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60570-0"},{"key":"2025120619244540000_9.3.e025831.5","unstructured":"Guidelines on the Management of Latent Tuberculosis Infection. World Health Organization, 2015. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/136471\/9789241548908_eng.pdf jsessionid=0FAF6CBF844C75B7770C124D7A055599?sequence=1 (accessed 2 Aug 2018)."},{"key":"2025120619244540000_9.3.e025831.6","unstructured":"Hopewell PC , Fair E , Miller C . Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. World Health Organization 2012 http:\/\/apps.who.int\/iris\/bitstream\/10665\/77741\/1\/9789241504492_eng.pdf (accessed 2 Aug 2018)."},{"key":"2025120619244540000_9.3.e025831.7","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199903110-00009"},{"key":"2025120619244540000_9.3.e025831.8","doi-asserted-by":"crossref","unstructured":"Smieja MJ , Marchetti CA , Cook DJ , et al . Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000:CD001363.doi:10.1002\/14651858.CD001363","DOI":"10.1002\/14651858.CD001363"},{"key":"2025120619244540000_9.3.e025831.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"2025120619244540000_9.3.e025831.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00009114"},{"key":"2025120619244540000_9.3.e025831.11","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-200295040-00009"},{"key":"2025120619244540000_9.3.e025831.12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.6.2004022"},{"key":"2025120619244540000_9.3.e025831.13","first-page":"S363","article-title":"Evaluation of tuberculosis contact investigations in California","volume":"7","author":"Sprinson","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025120619244540000_9.3.e025831.14","first-page":"S384","article-title":"Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999","volume":"7","author":"Jereb","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025120619244540000_9.3.e025831.15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00002030-199509030-00008","article-title":"Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre","volume":"9","author":"Aisu","year":"1995","journal-title":"AIDS"},{"key":"2025120619244540000_9.3.e025831.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111773","article-title":"High utility of contact investigation for latent and active tuberculosis case detection among the contacts: a retrospective cohort study in Tbilisi, Georgia, 2010-2011","volume":"9","author":"Chakhaia","year":"2014","journal-title":"PLoS One"},{"key":"2025120619244540000_9.3.e025831.17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2471\/BLT.13.118414","article-title":"Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia","volume":"91","author":"Rutherford","year":"2013","journal-title":"Bull World Health Organ"},{"key":"2025120619244540000_9.3.e025831.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2014.02.017"},{"key":"2025120619244540000_9.3.e025831.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2011.02951.x"},{"key":"2025120619244540000_9.3.e025831.20","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0060"},{"key":"2025120619244540000_9.3.e025831.21","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0511"},{"key":"2025120619244540000_9.3.e025831.22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.2.210"},{"key":"2025120619244540000_9.3.e025831.23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1057\/jos.2009.25","article-title":"Discrete event simulation for performance modelling in health care: a review of the literature","volume":"4","author":"G\u00fcnal","year":"2010","journal-title":"J Simul"},{"key":"2025120619244540000_9.3.e025831.24","doi-asserted-by":"crossref","unstructured":"Breslow NE . Cohort analysis in epidemiology. New York, NY: Springer, 1985:109\u201343.","DOI":"10.1007\/978-1-4613-8560-8_6"},{"key":"2025120619244540000_9.3.e025831.25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/0962280214552092","article-title":"Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials","volume":"26","author":"Scott","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"2025120619244540000_9.3.e025831.26","first-page":"96","volume-title":"International Statistical Review","volume":"75","author":"Demidenko","year":"2007"},{"key":"2025120619244540000_9.3.e025831.27","doi-asserted-by":"crossref","unstructured":"Dean CB , Lundy ER . Overdispersion. Wiley StatsRef: Statistics Reference Online, 2016:1\u20139.","DOI":"10.1002\/9781118445112.stat06788.pub2"},{"key":"2025120619244540000_9.3.e025831.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00070812"},{"key":"2025120619244540000_9.3.e025831.29","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025120619244540000_9.3.e025831.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040238"},{"key":"2025120619244540000_9.3.e025831.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60593-0"},{"key":"2025120619244540000_9.3.e025831.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17021-9"},{"key":"2025120619244540000_9.3.e025831.33","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70071-9"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-025831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:24:54Z","timestamp":1765077894000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-025831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,20]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/bmjopen-2018-025831"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-025831","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}